Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on Atopic Dermatitis Treatment with Baricitinib, Tralokinumab, Abrocitinib, Upadacitinib, and Dupilumab for Patients Needing Second-Line Systemic Therapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Spain
  • Study on Improving Treatment for Young Adults with Poor-Prognosis Non-Seminomatous Germ-Cell Tumors Using Paclitaxel and Drug Combination

    Recruiting

    2 1 1 1
    France
  • Long-Term Follow-Up Study for Patients Treated with Idecabtagene Vicleucel or Lisocabtagene Maraleucel for Cancer

    Recruiting

    4 1 1
    Austria Belgium Czechia Denmark Finland France +11
  • Study on the Use of Simoctocog Alfa and Emicizumab for Surgery in Patients with Severe Hemophilia A

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Croatia Finland France Germany Italy Spain
  • Study on the Use of Simoctocog Alfa for Women and Girls with Hemophilia A Undergoing Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Finland France Germany Italy Romania Spain
  • Study of Etripamil Nasal Spray for Children with Paroxysmal Supraventricular Tachycardia (Ages 6-18)

    Recruiting

    2 1 1
    Investigated Drugs:
    Germany The Netherlands Spain
  • Study on Long-term Safety and Tolerability of Atogepant for Children and Teens (Ages 6-17) with Migraine

    Recruiting

    3 1 1
    Investigated Drugs:
    Belgium Denmark France Hungary Italy The Netherlands +5
  • Study on Tocilizumab for Treating Acute Chest Syndrome in Children and Adults with Sickle Cell Disease

    Recruiting

    3 1 1
    Investigated Diseases:
    France
  • Study on Allogeneic Stem Cell Transplantation for Children and Adolescents with Acute Lymphoblastic Leukemia Using Etoposide, Treosulfan, and Thiotepa

    Recruiting

    4 1 1 1
    Austria Belgium Czechia Denmark France Germany +6
  • Study on the Effectiveness of Bevacizumab and Drug Combination for Children with Recurrent or Progressive Medulloblastoma, Ependymoma, and ATRT

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Austria Czechia Denmark France Norway Spain +1